U.S. FDA grants breakthrough device designation for innovative EndoSound vision ultrasound system

1 September 2021 - Endosound announced today that its EndoSound Vision System received a Breakthrough Device Designation from the U.S. FDA. ...

Read more →

MicroTransponder receives FDA approval for breakthrough device benefiting stroke survivors

31 August 2021 - MicroTransponder today announced US FDA premarket approval of the Vivistim Paired VNS System, which significantly improves the ...

Read more →

Zimmer Biomet and Canary Medical announce FDA de novo classification grant and authorisation to market the world's first and only smart knee implant

30 August 2021 - Post-operative gait metrics to provide real world, objective patient data. ...

Read more →

FDA grants breakthrough device designation for ImpediMed's SOZO digital health platform for renal failure

30 August 2021 - FDA recognises potential of SOZO digital health platform to assist clinicians in measuring exact fluid volume of ...

Read more →

FDA approves first of its kind stroke rehabilitation system

27 August 2021 - The U.S. FDA today approved the MicroTransponder Vivistim Paired VNS System (Vivistim System), a first-of-its-kind, drug-free rehabilitation ...

Read more →

Innovative Health Sciences receives FDA clearance for Insignis subcutaneous needle sets

26 August 2021 - Innovative Health Sciences announced today that it has received FDA clearance for its Insignis subcutaneous needle sets. ...

Read more →

FDA grants breakthrough device designation for renal failure

23 August 2021 - ImpediMed is pleased to announce SOZO has received FDA breakthrough device designation for a proposed indication ...

Read more →

FDA grants breakthrough device designation to Impella ECP, the world’s smallest heart pump

18 August 2021 - The United States FDA has granted breakthrough device designation to Abiomed’s Impella ECP expandable percutaneous heart ...

Read more →

Helius Medical Technologies announces FDA breakthrough device designation for the treatment of dynamic gait and balance deficits following a stroke

17 August 2021 - Helius Medical Technologies today announced that it has received breakthrough designation from the U.S. FDA for its ...

Read more →

Abbott's Amplatzer Amulet device approved by FDA to treat people with atrial fibrillation at risk of stroke

16 August 2021 - Amulet is the first and only minimally invasive treatment option to offer immediate closure of the left ...

Read more →

Second U.S. FDA breakthrough device designation granted to CytoSorbents' DrugSorb-ATR anti-thrombotic removal system adding the removal of market leading direct oral anti-coagulants during urgent cardiothoracic surgery

12 August 2021 - FDA breakthrough designation granted to CytoSorbents' DrugSorb-ATR for removal of apixaban and rivaroxaban to reduce the risk ...

Read more →

Reclassification of software based medical devices

12 August 2021 - Recent changes to regulation of software based medical devices came into effect in early 2021, which ...

Read more →

Swing Therapeutics receives FDA breakthrough device designation for digital therapeutic for the management of fibromyalgia, launches real world study

11 August 2021 - Approach based on acceptance and commitment therapy and a foundational clinically validated digital program licensed from University ...

Read more →

Altoida awarded FDA breakthrough designation for development of world’s first precision neurology device for prediction of Alzheimer's disease

5 August 2021 - Breakthrough designation will advance the development of industry’s first predictive diagnostic device for conversion to Alzheimer’s disease, ...

Read more →

Kestra Medical Technologies receives FDA premarket approval for ASSURE wearable cardioverter defibrillator

3 August 2021 - Kestra Medical Technologies announced today that the company has received U.S. FDA premarket approval for the ASSURE ...

Read more →